Active pharmaceutical ingredient watch. (Markets: Life Sciences).(pharmaceutical industry; news briefs)(Brief Article)

Chemical Market Reporter, September, 2002

APOTEX Corp. moved closer to marketing a generic version ofAbbott Laboratories bipolar disorder drug Depakote (divalproex sodium). The company says a federal appeals court reversed a summary judgement granted by a district court in Abbott's patent infringement lawsuit. The patent on Depakote expires in 2008. Banc of America Securities estimates US sales of $823 million and $897 million in 2002 and 2003, respectively.

BOEHRINGER-INGELHEIM GmbH forecasts a 2003 launch of once-daily inhaled Spiriva (tiotropium) to treat chronic obstructive pulmonary disease. A Food and Drug Administration (FDA) panel will review the drug in September. The drug will be co-marketed with Pfizer Inc. Analysts project nearly $1 billion in peak sales.

GENENTECH Inc. has...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement